GENOUS
TM
SUCCESS STORY
The right drug. The first time. Everytime
On a global scale, cancer brings patients and their families fear, obsession, and even financial exhaustion. Evolutionary mechanisms, sophisticated escape from cancer cell treatments make it one of the most insummissible diseases the world has ever faced. Cancer is like a dark cloud dancing in the sky, obscuring the shining golden sun, and making life lose the joyful scene. In that gloomy picture, it turns out that there are still rays of light for cancer patients.
All thanks to the continuous advances in the field of biomedicine and biomedical technology. New discoveries, new technologies are gradually helping people with cancer feel that it is no longer a nightmare with no way out. Of course, the fight against cancer has never had a pause, but humanity is getting to know it better, and finding more effective "Weapons".
Genomate's artificial intelligence (AI) drug prescription system was born, which has been gradually creating a revolution to promote digital, big data and artificial intelligence in cancer treatment. It helps the implementation of the concept of "Precision Oncology" (Precision Oncology) into practice more fully.
And through the success stories, spreading inspiration of some patients who have applied this solution, we will have more hope for a better future, if unfortunately facing tumors called "CANCER".
Long-term survival after metastatic cancer
Kataline is a middle-aged Hungarian woman who was diagnosed with lung cancer with brain metastases in 2012. At the time, her prognosis was just 3 months. Thanks to analysis by Oncompass (a Hungarian company that shares the DDA platform with Genomate),
A Game-Changer: A 34-Year-Old Athlete’s Battle with Adenoid Cystic Carcinoma (ACC
The 34-year-old athlete, the diagnosis of ACC in the left eye socket is a shock. This rare and aggressive cancer not only threatens his sports career, but also his life, especially when it has spread to the liver and bones.
Successful Clinical Trial Participation for a 62-Year-Old with Cervical Carcinom
At 62, this man’s world was turned upside down when he was diagnosed with cholangiocarcinoma, a rare and aggressive cancer of the bile ducts
A New Lease on Life: A 62-Year-Old Woman’s Fight Against NSCLC
Diagnosed with non-small cell lung cancer (NSCLC) and brain metastasis 12 years ago, the female patient - then 50 years old - faced a frightening prognosis of only 3 months to live.